HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Yokoyama Selected Research

beta-rubromycin

5/2000Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Yokoyama Research Topics

Disease

11Neoplasms (Cancer)
12/2008 - 03/2000
10Asthma (Bronchial Asthma)
08/2017 - 02/2000
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2015 - 02/2000
8Inflammation (Inflammations)
05/2014 - 02/2000
7Leukemia
12/2015 - 01/2001
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2015 - 07/2008
4Fibrosis (Cirrhosis)
02/2009 - 04/2000
3Neutropenia
07/2015 - 02/2009
3Eosinophilia
05/2014 - 10/2001
3Respiratory Hypersensitivity
02/2009 - 10/2001
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2007 - 04/2001
3Lymphoma (Lymphomas)
01/2006 - 07/2000
3Carcinogenesis
12/2001 - 03/2001
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
02/2017 - 01/2017
2Thrombotic Microangiopathies
01/2017 - 04/2010
2Infections
07/2015 - 08/2013
2Disseminated Intravascular Coagulation
01/2015 - 04/2008
2Esophageal Neoplasms (Esophageal Cancer)
02/2013 - 03/2001
2Pneumonia (Pneumonitis)
09/2012 - 09/2000
2Adenocarcinoma
09/2012 - 12/2001
2Pdgfra-Associated Chronic Eosinophilic Leukemia
12/2011 - 09/2010
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2011 - 09/2010
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2011 - 09/2010
2Thymoma (Thymic Carcinoma)
06/2010 - 11/2009
2Hematologic Neoplasms (Hematological Malignancy)
09/2009 - 01/2006
2Lung Neoplasms (Lung Cancer)
02/2009 - 12/2001
2Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
12/2001 - 01/2001
2Carcinoma (Carcinomatosis)
07/2000 - 06/2000
1Dermatitis Herpetiformis (Disease, Duhring's)
01/2022
1Edema (Dropsy)
02/2017
1Febrile Neutropenia
07/2015
1Alopecia (Baldness)
07/2015
1Persistent Infection
08/2013
1Cardiovascular Diseases (Cardiovascular Disease)
04/2012
1Philadelphia Chromosome
12/2011
1HELLP Syndrome
09/2010
1Asbestosis
01/2010

Drug/Important Bio-Agent (IBA)

8Cisplatin (Platino)FDA LinkGeneric
07/2015 - 12/2001
4ThrombomodulinIBA
02/2017 - 04/2010
4Proteins (Proteins, Gene)FDA Link
12/2015 - 03/2000
4AldehydesIBA
02/2013 - 03/2001
4AntigensIBA
02/2009 - 03/2000
4CytokinesIBA
02/2009 - 02/2000
3Etoposide (VP 16)FDA LinkGeneric
06/2010 - 05/2003
3Irinotecan (Camptosar)FDA LinkGeneric
02/2009 - 12/2000
2IodineIBA
01/2022 - 12/2001
2Small Interfering RNA (siRNA)IBA
12/2015 - 09/2009
2Drug CombinationsIBA
07/2015 - 06/2005
2Docetaxel (Taxotere)FDA Link
07/2015 - 01/2004
2PlatinumIBA
07/2015 - 07/2000
2AnticoagulantsIBA
01/2015 - 04/2012
2Adrenal Cortex Hormones (Corticosteroids)IBA
05/2014 - 12/2001
2Imatinib Mesylate (Gleevec)FDA Link
12/2011 - 09/2010
2Tyrosine Kinase InhibitorsIBA
09/2010 - 12/2009
2Dacarbazine (DIC)FDA LinkGeneric
09/2010 - 04/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2010 - 07/2000
2Vincristine (Oncovin)FDA LinkGeneric
06/2010 - 09/2009
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2009 - 02/2007
2Hydroxyproline (4 Hydroxyproline)IBA
02/2009 - 01/2003
2OvalbuminIBA
02/2009 - 10/2001
2Histone Deacetylase InhibitorsIBA
12/2008 - 07/2008
2Histone Acetyltransferases (Histone Acetyltransferase)IBA
12/2001 - 01/2001
2GemcitabineFDA Link
12/2001 - 07/2000
2AcetaldehydeIBA
12/2001 - 05/2001
2Immunoglobulin E (IgE)IBA
10/2001 - 02/2000
2Ethanol (Ethyl Alcohol)IBA
05/2001 - 03/2001
2Aldehyde DehydrogenaseIBA
03/2001 - 01/2000
2Cyanamide (Calcium Carbimide)IBA
04/2000 - 04/2000
1Contrast MediaIBA
01/2022
1Genetic Markers (Genetic Marker)IBA
08/2017
1Calcineurin InhibitorsIBA
01/2017
1MonocrotalineIBA
01/2017
1Caspase 3 (Caspase-3)IBA
12/2015
1STAT5 Transcription FactorIBA
12/2015
1TetraspaninsIBA
12/2015
1S-1 plus cisplatinIBA
07/2015
1SteroidsIBA
05/2014
1GlucocorticoidsIBA
05/2014
1PeriostinIBA
05/2014
1Lipoproteins (Lipoprotein)IBA
08/2013
1Gefitinib (Iressa)FDA Link
09/2012
1ErbB Receptors (EGF Receptor)IBA
09/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2011
1DNA Methyltransferase 3AIBA
12/2011
1Histone MethyltransferasesIBA
12/2011
1Enhancer of Zeste Homolog 2 ProteinIBA
12/2011
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2011
1TensinsIBA
12/2011
1AsbestosIBA
01/2010
1Interleukin-6 (Interleukin 6)IBA
12/2009
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2009
1Sunitinib (Sutent)FDA Link
11/2009
11,25-dihydroxyvitamin DIBA
11/2009

Therapy/Procedure

7Drug Therapy (Chemotherapy)
12/2015 - 04/2001
4Radiotherapy
09/2012 - 06/2000
3Hematopoietic Stem Cell Transplantation
02/2017 - 02/2007
3Therapeutics
04/2012 - 07/2000
1Induction Chemotherapy
09/2012
1Aftercare (After-Treatment)
12/2011
1Transplantation
04/2010